Andrews BS et al. Spontaneous murine lupus-like syndrome, clinical and immunopathological manifestations in several strains. J Exp Med1978; 148: 1198-1215.
2.
Steinberg ADInsights into the basis of systemic lupus. J Autoimmunity1995; 8: 771-785.
3.
Theofilopoulos AN, Dixon FJEtiopathogenesis of murine SLE. Immunol Rev1981; 55: 179-216.
4.
Murphy ED, Roths JBAutoimmunity and lymphoproliferation. Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Bigazzi PE, Warner NL (eds). Genetic Control of Autoimmune DiseaseElsevier: New York, 1978; pp 207-221.
5.
Furukawa F. et al. Pathogenesis of lupus dermatoses in autoimmune mice. IV. association betewen cutaneous immunoglobulin deposition and anti-single-stranded DNA antibodies in sera. Arch Dermatol Res1985; 277: 79-83.
6.
Furukawa F. et al. New horizons in murine lupus dermatoses. Proc Jpn Soc Invest Dermatol1986; 10: 57-62.
7.
Izui S. et al. Mechanisms of genetic control of murine systemic lupus erythematosus . Springer Semin Immunopathol1994; 16: 133-152.
8.
Furukawa F. et al. Genetic studies on the skin lupus band test in New Zealand mice . Clin Exp Immunol1985; 59: 146-152.
9.
Furukawa F. et al. Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res1984; 276: 186-194.
10.
Furukawa F. et al. Spontaneous autoimmune skin lesions of MRL/n mice-autoimmune disease-prone genetic background in relation to Fas-defect MRL/1pr mice. J Invest Dermatol1996; 107: 95-100.
11.
Watanabe-Fukunaga R. et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature1992; 356: 314-317.
12.
Kanauchi H. , Furukawa F., Imamura S.Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J Invest Dermatol1991 ; 96: 478-483.
13.
Horiguchi Y. et al. Ultrastructural lupus band test in skin of MRL/1 mice. Arch Dermatol Res1986; 278: 474-480.
14.
Provost TT, Watson R. TheMRL/lpr mouse model of cutaneous lupus. In: Wallace DJ, Hahn BH (eds). Dubois' Lupus Erythematosus (4th edn). Lea & Febiger: Philadelphia, 1993, pp 282.
15.
Horiguchi Y. et al. Ultrastructural observations of skin lesions in MRL mice—dermoepidermal junction. Arch Dermatol Res1984; 276: 229-234.
16.
Horiguchi Y. , Furukawa F., Imamura S.Ultrastructural observations of skin lesions in MRL mice-dermal infiltrations and capillary changes. J Dermatol1986; 6: 440-447.
17.
Furukawa F. et al. The uterus lupus band test and its correlation with the skin lupus band test in autoimmune mice. Microbiol Immunol1986; 30: 395-400.
18.
Horiguchi Y. et al. Comparative electron and immunoelectron microscopic studies on immunoglobulin deposits in the glomeruli of the kidney, skin, esophagus and uterus of MRL/1 mice. Acta Histochem Cytochem1987; 20: 217-227.
19.
Furukawa F. et al. Pathogenesis of lupus dermatoses in autoimmune mice. VI. correlation between positivity of lupus band test and lupus nephritis . Arch Dermatol Res1986; 278: 343-346.
20.
Kitajima T. et al. Histological detection of c-myb and c-myc proto-oncogene expression in infiltrating cells in cutaneous lupus erythematosus-like lesions of MRL/1 mice by in situ hybridization. Clin Immunol Immunopathol1992; 62: 119-123.
21.
Furukawa F. , Kanauchi H., Imamura S.Susceptibility to UVB light in cultured keratinocytes of cutaneous lupus erythematosus. Dermatology1994; 189 (suppl. 1): 18-23.
22.
Theofilopoulos ANThe basis of autoimmunity: Part II, Genetic predisposition. Immunol Today1995; 16: 150-159.
23.
Takahashi S. et al. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol1991; 147: 515-519.
24.
Gyotoku Y. et al. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/Mp-1pr/1pr mice. J Immunol1987 ; 138: 3785-3792.
25.
Velthuis PJ et al. In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies . Ann Rheum Dis1990; 49: 163-167.
26.
Burrows NP et al. Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence. J Cutan Pathol1993; 20: 159-162.
27.
Alarcon-Segovia D., Ruiz-Arguelles A., Fishbein E.Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors . Nature1978; 271: 67-69.
28.
Galoppin L. , Saurat JHIn vitro study of the binding of antiribonucleoprotein antibodies to the nucleus of isolated living keratinocytes. J Invest Dermatol1981; 76: 264-267.
29.
Maruyama N. et al. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB x NZW) F1 hybrid and the correlation to renal disease. J Immunol1983; 130: 740-746.
30.
Shirai T. et al. Naturally occurring antibody response to DNA is associated with the response to retroviral gp70 in autoimmune New Zealand mice. Arthritis Rheum1986; 29: 242-250.
31.
Furukawa F. , Ohshio G., Imamura S.Pathogenesis of lupus dermatoses in autoimmune mice. XIX. Attempts to induce subepidermal immunoglobulin deposition in MRL/Mp - +/+ mice. Arch Dermatol Res1993; 285: 20-26.
32.
Berney T. et al. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol1992; 4: 93-99.
33.
Horiguchi Y. et al. Effects of ultraviolet light irradiation on the skin of MRL/1 mice. Arch Dermatol Res1987; 279: 478-483.
34.
Furukawa et al. Relationship between heat shock protein induction and the binding of antibodies to the extractable nuclear antigens on cultured human keratinocytes . J Invest Dermatol1993; 101: 191-195.
35.
Bielschowsky M., Helyer BJ, Howie JBSpontaneous anemia in mice of the NZB/BL strain . Proc Univ Otago Med Sch1959; 37: 9-11.
36.
Howie JB, Helyer BJThe immunology and pathology of NZB mice. Adv Immunol1968; 9: 2215-266.
37.
Shirai T.The genetic basis of autoimmunity in murine lupus. Immunol Today1982; 7: 187-194.
38.
Kono DH et al. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA1994; 91: 10168-10172.
39.
Drake CG et al. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc Natl Acad Sci USA1994; 91: 4062-4066.
40.
Gilliam JN, Hurd ER, Ziff M.Subepidermal deposition of immunoglobulin in NZB/NZW F1 hybrid mice. J Immunol1975; 114: 133-137.
41.
Sontheimer RD, Gilliam JNRegional variation in the deposition of subepidermal immunoglobulin in NZB/W F1 mice: association with epidermal DNA synthesis. J Invest Dermatol1979; 72: 25-28.
42.
Furukawa F. , Hamashima Y.Lupus band test in New Zealand mice and MRL mice. J Dermatol1982; 9: 467-471.
43.
Nakamura K. et al. Spontaneous degenerative polyarthritis in male New Zealand Black/KN mice. Arthritis Rheum1991; 34: 171-179.
44.
Furukawa F.Pathogenesis of autoimmune alopecia. Rinsho Hifuka (in press) (in Japanese).
45.
Tamada Y. et al. Pathological studies on NC mouse with erythema and alopecia . Jpn J Allergol1976; 25: 829-836.
46.
Kondo K., Nagami T., Teramoto S.Differences in hematopoietic death among inbred strains of mice. In Bond PV and Sugahara T (eds). Comparative cellular and Species Radiosensitivity Igakushoin ; Tokyo, 1969, pp 20-29.
47.
Oyaizu N. et al. (NZW x BXSB) F1 mouse, a new animal model of idiopathic thrombocytopenic purpura. J Exp Med1988; 167: 2017-2022.
48.
Monestier M. et al. Monoclonal antibodies from NZW x BXSB F1 mice to β2-glycoprotein I and cardiolipin. J Immunol1996; 156: 2631-2641.
49.
Merino R. et al. The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB x BXSB)F1 hybrid mice. J Clin Invest1994; 94: 521-525.
50.
Vidal S., Gelpi C., Rodriguez-Sanchez JL. (SWR x SJL)F1 mice: a new model of lupus-like disease. J Exp Med1994; 179: 1429-1435.
51.
Sontheimer RDPhotoimmunology of lupus erythematosus and dermatomyositis: a speculative review. Photochem Photobiol1996; 63: 583-594.
52.
Natali PG, Tan EMExperimental skin lesions in mice resembling systemic lupus erythematosus . Arthritis Rheum1973; 16: 579-589.
53.
Imamura S.Skin lesion of SLE and its pathomechanisms. NishinihonJ Dermatol1981; 43: 1119-1125 (abstract in English).
Kochevar IEAction spectrum and mechanisms of UV radiation-induced injury in lupus erythematosus . J Invest Dermatol1985; 85: 140S-143S.
56.
Halpern B., Emerit I., Housset E.Possible autoimmune processes related to chromosomal abnormalities (breakage) in NZB mice. Nature1972; 235: 214-215.
57.
Reddy AL, Fialkow PJ, Salo A.Ultraviolet radiation-induced chromosomal abnormalities in fetal fibroblasts from New Zealand black mice. Science1978; 201: 920—922.
58.
Emerit I.Chromosome breakage factors: origin and possible significance. Proc Muta Res1982; 4: 61-74.
59.
Zamanski GB et al. Effect of ultraviolet light irradiation on the survival of New Zealand black mouse cells. Arthritis Rheum1980; 23: 866-867.
60.
Natali PG, Mottolese M., Nicotra M.Immune complex formation in NZB/W mice after ultraviolet radiation. Clin Immunol Immunopathol1978; 10: 414-419.
61.
Davis P., Percy JSEffect of ultraviolet light on disease characteristics of NZB/W mice. J Rheumatol1978; 5: 125-128.
62.
Ansel JC et al. Effects ofUV radiation on autoimmune strains of mice: increased mortality and accelerated autoimmunity in BXSB mice. J Invest Dermatol1985; 85: 181-186.
63.
Furukawa F. , Lyons MB, Norris DASusceptible cytotoxicity to ultraviolet B light in fibroblasts and keratinocytes cultured from autoimmune-prone MRL/Mp-lpr/lpr mice. Clin Immunol Immunopathol1989; 52: 460-472.
64.
Golan DT, Borel Y.Increased photosensitivity to near-ultraviolet light in murine SLE. J Immunol1984 ; 132: 705-710.
65.
McGrath Jr H.Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus . Clin Exp Rheumatol1994; 12: 129-135.
66.
Gleichmann E., Van Elven EH, Van der Veen Jpw.A systemic lupus erythematosus(SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur J Immunol1982; 12: 152-159.
67.
Van Rappard-Van Der Veen FM et al. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. J Immunol1983; 130: 2693—2701.
68.
Gelpi C. et al. Murine graft vs host disease. A model for study of mechanisms that generate autoantibodies to ribonucleoproteins. J Immunol1988; 140: 4160-4166.
69.
Appleby P., Webber DG, Bowen JGMurine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development. Clin Exp Immunol1989; 78: 449-453.
70.
Girardi M., Herreid P., Tigelaar RESpecific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes. J Invest Dermatol1995; 104: 177-182.
71.
Maeda T., Nomoto K.Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels. J Rheumatol1995; 22: 2259-2265.
72.
Vladutiu AOThe severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol1993; 93: 1-8.
73.
Duchosal MA et al. Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med1990; 172: 985-988.
74.
Reininger L. et al. Development of autoimmune disease in SCID mice populated with long-term 'in vitro' proliferating (NZB x NZW)F 1 pre-B cells. J Exp Med1992; 176: 1343-1353.
75.
Segal R. et al. Induction of experimental systemic lupus erythematosus (SLE) in mice with severe combined immunodeficiency (SCID). Clin Exp Immunol1992; 89: 239-243.
76.
Sneller MC et al. A novel lymphoproliferative/autoimmune syndrome resembling murine 1pr /gld disease. J Clin Invest1992; 90: 334-341.
77.
Dauphinee MJ et al. Interleukin 2 deficiency is a common feature of autoimmune mice. J Immunol1981 ; 127: 2483-2487.
78.
Tang B. et al. Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol1991; 3: 273-278.
79.
Finck BK, Chan B., Wofsy D.Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest1994; 94: 585-591.
80.
Klinman DM, Steinberg ADInquiry into murine and human lupus. Immunol Rev1995; 144: 157-193.
81.
Takahashi S. et al. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice . J Clin Invest1996; 97: 1597-1604.
82.
Dang H. et al. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-b knockout mice. J Immunol1995; 155: 3205-3212.
83.
Shoenfeld Y.Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome. Transplant Proc1994; 26: 3211-3213.
84.
Gilkeson GS et al. Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-1pr/1pr mice. Clin Immunol Immunopathol1992; 64: 166-172.
85.
Finck BK, Linsley PS, Wofsy D.Treatment of murine lupus with CTLA4Ig. Science1994; 265: 1225-1227.
86.
Kanauchi H. , Imamura S., Takigawa M., Furukawa F.Effects of cyclosporin A on lupus dermatoses in autoimmune-prone MRL/Mp-lpr /1pr mice. J Dermatol Treat1994; 5: 187-191.
87.
Kanauchi H. , Imamura S., Takigawa M., Furukawa F.Evaluation of the Japanese-Chinese herbal medicine, Kampo, for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice. J Dermatol1994; 21: 935-939.
88.
Furukawa F. , Imamura S., Takigawa M.KF506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. Arch Dermatol Res1995; 287: 558-563.
